Medtronic, Inc. announced FDA approval and U.S. launch on 6 May 2013 of its newest cardiac devices: the Viva portfolio...
Medtronic, Inc. has announced the FDA approval of its newest cardiac resynchronization therapy-pacemaker, Viva CRT-P, for indicated patients with Heart...
Medtronic has announced new data supporting the clinical and economic value of its cardiac resynchronization therapy (CRT) devices: Viva XT...
Medtronic Inc has received CE Mark in Europe for its Viva and Brava Cardiac Resynchronization Therapy with Defibrillation (CRT-D) devices...
New data from the Medtronic, Inc. Adaptive CRT trial shows a 61 percent (p=0.01) lower risk of Atrial Fibrillation (AF)-related...
Medtronic, Inc.announced clinical trial results showing that Heart Failure patients treated with its exclusive AdaptivCRT feature (in the Medtronic Viva...
Boston Scientific announced positive results for the EkoSonic Endovascular System (EKOS system) during a late-breaking clinical trial presentation at the Vascular InterVentional Advances (VIVA) meeting in Las Vegas.
Boston Scientific announced positive results for the Ranger Drug-Coated Balloon (DCB) during a late-breaking clinical trial presentation at the Vascular InterVentional Advances (VIVA) meeting in Las Vegas.
Canon Medical is releasing a new high-end digital PET/CT scanner at the upcoming RSNA conference in Chicago. The Cartesion Prime...
Arineta Ltd has secured FDA approval on 19 August 2016 for its Spotlight CT Cardiac Scanner. SpotLight CT is a...